[Pahlnet] FW: Infuenza

Tue Oct 27 20:07:10 EST 2009

Very interesting Elva. Thanks. At least now SDC is effective against
H1N1 2009.

From: pahlnet-bounces at lists.spc.int
[mailto:pahlnet-bounces at lists.spc.int] On Behalf Of Elva Borja
Sent: Wednesday, October 28, 2009 12:46 PM
To: pahlnet at lists.spc.int
Subject: [Pahlnet] FW: Infuenza

FYI.

From: Ken Cokanasiga 
Sent: Wednesday, 28 October 2009 12:43 PM
To: Pacific Heads of Veterinary and Animal Production Services
Cc: PRIPPP
Subject: Infuenza

Courtesy of Dr David Thomson

EPA-Registered Ionic Silver Disinfectant Effective Against 2009 H1N1 Flu
Strain

Tue Oct 27, 2009 8:27am EDT

http://www.reuters.com/article/pressRelease/idUS135744+27-Oct-2009+BW200
91027

Email
<javascript:commonPopup('/do/emailArticle?articleId=US135744%2B27-Oct-20
09%2BBW20091027',%20540,%20600,%201,%20'emailPopup')>  | Print
<http://www.reuters.com/articlePrint?articleId=US135744%2B27-Oct-2009%2B
BW20091027>  | 

Share

| Reprints <http://parsintl.com/reutersquote>  | Single Page
<javascript:singlePageView();> 

[- <javascript:sizeDown();> ] Text <javascript:resetCurrentsize();>  [+
<javascript:sizeUp();> ] 

Featured Broker sponsored link

<http://ad.doubleclick.net/click;h=v8/38d4/0/0/%2a/l;44306;0-0;0;3891907
4;1627-170/40;0/0/0;;~okv=;type=featured_broker;sz=170x40;articleID=US13
5744%2027-Oct-2009%20BW20091027;~aopt=2/1/ff/1;~sscs=%3f> 

PURE Bioscience Praises FDA`s Actions to Squelch Unregistered Claims for

Silver-Based Products

SAN DIEGO--(Business Wire)--

PURE Bioscience (NASDAQ:PURE), creators of the patented silver
dihydrogen

citrate (SDC) antimicrobial, announced today that its SDC-based hard
surface

disinfectant is effective against the 2009 H1N1 and is included on the
list

published by the U.S. Environmental Protection Agency (EPA) of
antimicrobial

products effective against the 2009 H1N1 flu strain based on their
effectiveness

against other influenza A virus strains. PURE Bioscience`s SDC
disinfectant also

meets the recommendations established by the U.S. Centers for Disease
Control

(CDC) for infection control of H1N1 in both home and healthcare
settings. 

"President Obama this weekend declared the H1N1 pandemic a national
emergency.

We are proud to offer government, business and the public a powerful and

effective weapon in the battle against H1N1," said Michael L. Krall,
President

and CEO of PURE Bioscience. 

"Our ionic silver disinfectant formula quickly and completely eliminates

bacteria, fungi and viruses, including 2009 H1N1, while using
astoundingly small

amounts of silver -- only 30 parts per million. We continue to invest
heavily to

develop, patent and obtain regulatory clearances for SDC, including our

EPA-registered hard surface disinfectant," added Krall. 

Based on the EPA toxicity ratings from Category I (high toxicity) down
to

Category IV, SDC disinfectant is a Category IV antimicrobial for which

precautionary labeling statements are not required. This compares with
Category

II warning statements for most leading brands of disinfectant products.
SDC

disinfectant has been registered by the EPA specifically for use on
children`s

toys, cribs, high chairs and other sensitive areas of the home as well
as for

use on hard surfaces in multitudes of environments, including hospitals,
schools

and offices. 

"Unsubstantiated and unapproved claims to kill H1N1 should not be
tolerated in

the marketplace, and we applaud the FDA`s recent warnings against
companies that

are seeking to profit from this pandemic using false claims about their

products," Krall said. "Influenza, including H1N1, continues to be a
serious and

growing public health threat. Consumers should only trust products that
have

been reviewed and approved by appropriate regulatory agencies. In
addition,

regarding environmental antimicrobials in particular, consumers should
read

labels carefully to understand the differences between products that
disinfect

versus those that only sanitize." 

Products registered by the EPA as "disinfectants" provide complete
elimination

of specifically claimed microorganisms; "sanitizers" merely reduce the
number of

microorganisms. 

PURE Bioscience`s broad spectrum SDC-based disinfectant completely
eliminates

bacteria, viruses and fungi and is registered with the EPA under the
trade name

Axen30. Independent lab studies and resulting EPA-registered claims
document

that PURE`s disinfectant kills resistant strains of bacteria, including
MRSA

(Methicillin-resistant Staphylococcus aureus), CA-MRSA, PVL-MRSA and VRE

(Vancomycin resistant Enterococcus faecium) in just 2 minutes. In
addition,

SDC-based disinfectant provide a 30-second kill time on Pseudomonas
aeruginosa

and Salmonella enteric and a 24-hour residual kill on standard indicator

bacteria. Important viral efficacy claims for PURE`s disinfectant
include a

3-minute kill against Human Corona virus (SARS surrogate) and Rotavirus
and a

10-minute kill against Norovirus, Human Influenza A and Avian Influenza
A (Bird

Flu). In addition, SDC- disinfectant is odorless, colorless,
non-corrosive,

non-flammable and is compatible with other disinfecting and cleaning
chemicals. 

About PURE Bioscience

PURE Bioscience develops and markets technology-based bioscience
products that

provide solutions to numerous global health challenges. PURE's
proprietary high

efficacy/low toxicity bioscience technologies, including its silver
dihydrogen

citrate-based antimicrobials, represent innovative advances in diverse
markets

and lead today's global trend toward industry and consumer use of
"green"

products while providing competitive advantages in efficacy and safety.
Patented

SDC is an electrolytically generated source of stabilized ionic silver
which

formulates well with other compounds. As a platform technology, SDC is

distinguished from competitors in the marketplace because of its
superior

efficacy, reduced toxicity and the inability of bacteria to form a
resistance to

it. PURE is headquartered in El Cajon, California (San Diego
metropolitan area).

Additional information on PURE is available at www.purebio.com. 

This press release includes statements that may constitute
"forward-looking"

statements, usually containing the words "believe," "estimate,"
"project,"

"expect" or similar expressions. These statements are made pursuant to
the safe

harbor provisions of the Private Securities Litigation Reform Act of
1995.

Forward-looking statements inherently involve risks and uncertainties
that could

cause actual results to differ materially from the forward-looking
statements.

Factors that would cause or contribute to such differences include, but
are not

limited to, acceptance of the Company's current and future products and
services

in the marketplace, the ability of the Company to develop effective new
products

and receive regulatory approvals of such products, competitive factors,

dependence upon third-party vendors, and other risks detailed in the
Company's

periodic report filings with the Securities and Exchange Commission. By
making

these forward-looking statements, the Company undertakes no obligation
to update

these statements for revisions or changes after the date of this
release.

Investor Contact:

Bibicoff + MacInnis, Inc.

Dr Ken Cokanasiga

Adviser, Animal Health and Production

Land Resources Division

Secretariat of the Pacific Community

Nabua

Suva

Fiji

Phone No : 679-337 0733

Fax No       : 679-337 0021

E mail : kenc at spc.int

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.spc.int/pipermail/pahlnet_lists.spc.int/attachments/20091028/276c714a/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: image/gif
Size: 43 bytes
Desc: image001.gif
URL: <http://lists.spc.int/pipermail/pahlnet_lists.spc.int/attachments/20091028/276c714a/attachment-0001.gif>